Biomerica Inc.

NASDAQ: BMRA · Real-Time Price · USD
3.44
0.41 (13.53%)
At close: Aug 14, 2025, 3:59 PM
3.09
-10.17%
Pre-market: Aug 15, 2025, 07:25 AM EDT

Biomerica Income Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021
Revenue
5.42M 5.34M 18.87M 7.2M
Cost of Revenue
4.8M 4.89M 15.89M 6.7M
Gross Profit
611K 446K 2.98M 496.98K
Operating Income
-6.37M -7.22M -4.53M -6.52M
Interest Income
431K 133K 27K 66.86K
Pretax Income
-5.94M -7.09M -4.51M -6.46M
Net Income
-5.98M -7.14M -4.53M -6.47M
Selling & General & Admin
5.49M 6.08M 5.7M 4.61M
Research & Development
1.49M 1.58M 1.81M 2.41M
Other Expenses
n/a 1K n/a n/a
Operating Expenses
6.98M 7.67M 7.51M 7.02M
Interest Expense
n/a n/a n/a 367.00
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.78M 12.56M 23.41M 13.72M
Income Tax Expense
42K 51K 23.72K 13.06K
Shares Outstanding (Basic)
16.82M 14.15M 12.67M 11.93M
Shares Outstanding (Diluted)
16.82M 14.15M 12.67M 11.93M
EPS (Basic)
-0.36 -0.5 -0.36 -0.54
EPS (Diluted)
-0.36 -0.5 -0.36 -0.54
EBITDA
-5.99M -6.74M -3.94M -7.06M
EBIT
-6.37M -7.22M -4.53M -7.43M
Depreciation & Amortization
374K 351K 594.82K 375.86K